| scholarly article | Q13442814 |
| P2093 | author name string | B Y Rubin | |
| H W Murray | |||
| C D Rothermel | |||
| D Wellner | |||
| A M Granger | |||
| M J Oca | |||
| A Szuro-Sudol | |||
| D M Libby | |||
| P2860 | cites work | Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma | Q33554419 |
| Production of and in vitro response to interleukin 2 in the acquired immunodeficiency syndrome | Q34565648 | ||
| Induction of pulmonary indoleamine 2,3-dioxygenase by interferon | Q35300850 | ||
| Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan | Q36254619 | ||
| Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens | Q36343315 | ||
| Role for endogenous and acquired peroxidase in the toxoplasmacidal activity of murine and human mononuclear phagocytes | Q36983087 | ||
| Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine | Q36992102 | ||
| Gamma-interferon-induced inhibition of the growth of Rickettsia prowazekii in fibroblasts cannot be explained by the degradation of tryptophan or other amino acids | Q37010640 | ||
| Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells | Q37026650 | ||
| Oxygen-independent inhibition of intracellular Chlamydia psittaci growth by human monocytes and interferon-gamma-activated macrophages | Q37902808 | ||
| The anti-chlamydial and anti-proliferative activities of recombinant murine interferon-gamma are not dependent on tryptophan concentrations. | Q37903686 | ||
| Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma | Q37903928 | ||
| Gamma-interferon is the factor in lymphokine that activates human macrophages to inhibit intracellular Chlamydia psittaci replication. | Q37906618 | ||
| Lymphokine enhances oxygen-independent activity against intracellular pathogens | Q37906871 | ||
| Indoleamine 2,3-dioxygenase. Purification and some properties | Q39196665 | ||
| Interferon-gamma, the activated macrophage, and host defense against microbial challenge | Q39601454 | ||
| Oxygen Metabolism and the Toxic Properties of Phagocytes | Q40122453 | ||
| Mechanisms of macrophage antimicrobial activity | Q40167273 | ||
| Activation of human macrophages. Comparison of other cytokines with interferon-gamma | Q42232581 | ||
| Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and -independent leishmanicidal activity | Q42789825 | ||
| Interferon-gamma suppresses the growth of Toxoplasma gondii in human fibroblasts through starvation for tryptophan | Q45350192 | ||
| Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. | Q50897682 | ||
| Characterization of an indoleamine 2,3-dioxygenase induced by gamma-interferon in cultured human fibroblasts | Q68971567 | ||
| Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures | Q69005518 | ||
| Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma | Q69937763 | ||
| Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii | Q70078033 | ||
| The actions of interferon and antiinflammatory agents of induction of indoleamine 2,3-dioxygenase in human peripheral blood monocytes | Q70339987 | ||
| The anticellular and protein-inducing activities of human gamma interferon preparations are mediated by the interferon | Q70425115 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | macrophage | Q184204 |
| P304 | page(s) | 845-849 | |
| P577 | publication date | 1989-03-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages | |
| P478 | volume | 57 |
| Q88229225 | A latent ability to persist: differentiation in Toxoplasma gondii |
| Q34364948 | Activation of indoleamine 2,3-dioxygenase in patients with scrub typhus and its role in growth restriction of Orientia tsutsugamushi |
| Q36955287 | Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules |
| Q37727828 | Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases |
| Q34082874 | Axenic Leishmania amazonensis promastigotes sense both the external and internal arginine pool distinctly regulating the two transporter-coding genes. |
| Q40164692 | Beta interferon inhibits Toxoplasma gondii growth in human monocyte-derived macrophages. |
| Q34955749 | CD73-generated adenosine is critical for immune regulation during Toxoplasma gondii infection |
| Q36444692 | Chlamydia trachomatis-specific human CD8+ T cells show two patterns of antigen recognition |
| Q33751943 | Chlamydial infection in inducible nitric oxide synthase knockout mice |
| Q34121590 | Dendritic cells as effector cells: gamma interferon activation of murine dendritic cells triggers oxygen-dependent inhibition of Toxoplasma gondii replication |
| Q34007988 | Differential infectivity and division of Toxoplasma gondii in human peripheral blood leukocytes |
| Q39573333 | Effect of cytokines on growth of Toxoplasma gondii in murine astrocytes |
| Q36367987 | Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii |
| Q41304128 | Establishment of T-helper type 1- and T-helper type 2-like human Toxoplasma antigen-specific T-cell clones |
| Q41470807 | Evaluation of radiofluorinated carboximidamides as potential IDO-targeted PET tracers for cancer imaging |
| Q33570163 | Evolution to a chronic disease niche correlates with increased sensitivity to tryptophan availability for the obligate intracellular bacterium Chlamydia pneumoniae |
| Q39653727 | Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1. |
| Q38092233 | Feast or famine: the host-pathogen battle over amino acids. |
| Q37894136 | Gamma interferon-activated human macrophages and Toxoplasma gondii, Chlamydia psittaci, and Leishmania donovani: antimicrobial role of limiting intracellular iron |
| Q37891650 | Gamma interferon-induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells. |
| Q71808689 | Granulocyte-macrophage colony-stimulating factor (GM-CSF) reduces toxoplasmastatic activity of human monocytes via induction of prostaglandin E2 (PGE2) |
| Q92956896 | Host cell depletion of tryptophan by IFNγ-induced Indoleamine 2,3-dioxygenase 1 (IDO1) inhibits lysosomal replication of Coxiella burnetii |
| Q34321262 | IL-17A synergizes with IFN-γ to upregulate iNOS and NO production and inhibit chlamydial growth |
| Q24612341 | Immune response and immunopathology during toxoplasmosis |
| Q34005898 | In vitro investigation of host resistance to Toxoplasma gondii infection in microglia of BALB/c and CBA/Ca mice |
| Q36377044 | Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii |
| Q34527995 | Induction of bradyzoite-specific Toxoplasma gondii antigens in gamma interferon-treated mouse macrophages |
| Q34200205 | Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. |
| Q41163543 | Infection of human monocytes by Leishmania results in a defective oxidative burst. |
| Q35644145 | Inflammation and repeated infections in CGD: two sides of a coin |
| Q34145731 | Inhibition by interferon-gamma of human mononuclear cell-mediated low density lipoprotein oxidation. Participation of tryptophan metabolism along the kynurenine pathway |
| Q34532614 | Inhibition of Legionella pneumophila growth by gamma interferon in permissive A/J mouse macrophages: role of reactive oxygen species, nitric oxide, tryptophan, and iron(III). |
| Q91890897 | Innate, adaptive, and cell-autonomous immunity against Toxoplasma gondii infection |
| Q35316535 | Interferons 1992. How much of the promise has been realised? |
| Q37144991 | Intralesional regulatory T-cell suppressive function during human acute and chronic cutaneous leishmaniasis due to Leishmania guyanensis |
| Q33583816 | Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects |
| Q34116625 | L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase |
| Q35525415 | Lavender oil suppresses indoleamine 2,3-dioxygenase activity in human PBMC |
| Q37878373 | Lymphotoxin inhibits Chlamydia pneumoniae growth in HEp-2 cells. |
| Q34287451 | M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection |
| Q36367801 | Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani |
| Q35211714 | Mechanisms of innate resistance to Toxoplasma gondii infection |
| Q35524566 | Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells |
| Q33455547 | Modeling infectious disease in mice: co-adaptation and the role of host-specific IFNgamma responses |
| Q37885104 | Molecular mechanism of T-cell control of Chlamydia in mice: role of nitric oxide in vivo |
| Q26741117 | Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease |
| Q30451043 | Murine gamma interferon fails to inhibit Toxoplasma gondii growth in murine fibroblasts |
| Q92578008 | Neurotoxic potential of reactive astrocytes in canine distemper demyelinating leukoencephalitis |
| Q27692028 | New Insights into IDO Biology in Bacterial and Viral Infections |
| Q41458561 | Nitrite production by macrophages derived from BCG-resistant and -susceptible congenic mouse strains in response to IFN-gamma and infection with BCG. |
| Q35623712 | Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection |
| Q90709433 | Paradoxical Pro-inflammatory Responses by Human Macrophages to an Amoebae Host-Adapted Legionella Effector |
| Q37592659 | Protozoan Parasites and Type I IFNs |
| Q33975360 | Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. |
| Q21285076 | Remarkable role of indoleamine 2,3-dioxygenase and tryptophan metabolites in infectious diseases: potential role in macrophage-mediated inflammatory diseases |
| Q33867034 | Replication of Toxoplasma gondii, but not Trypanosoma cruzi, is regulated in human fibroblasts activated with gamma interferon: requirement of a functional JAK/STAT pathway |
| Q36968666 | Role of beta interferon in resistance to Toxoplasma gondii infection |
| Q37346988 | Role of gamma interferon in Toxoplasma gondii infection |
| Q35476035 | Stable DNA transformation in the obligate intracellular parasite Toxoplasma gondii by complementation of tryptophan auxotrophy |
| Q37050204 | The end of the road for the tryptophan depletion concept in pregnancy and infection |
| Q34219774 | The immunotherapeutic role of regulatory T cells in Leishmania (Viannia) panamensis infection |
| Q95819594 | The molecular mechanism of T-cell control of Chlamydia in mice: role of nitric oxide |
| Q46676437 | Toll-like receptor-4-mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors |
| Q34534147 | Toxoplasma gondii soluble antigen induces a subset of lipopolysaccharide-inducible genes and tyrosine phosphoproteins in peritoneal macrophages. |
| Q35550138 | Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection |
| Q35104566 | Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon |
| Q61795846 | Tryptophan-kynurenine pathway attenuates β-catenin-dependent pro-parasitic role of STING-TICAM2-IRF3-IDO1 signalosome in Toxoplasma gondii infection |
Search more.